Clinical applicability of the Framingham 30-year risk score. Usefulness in cardiovascular risk stratification and the diagnosis of carotid atherosclerotic plaque;Aplicabilidad clínica de la función de Framingham a 30 años. Utilidad en la estratificación del riesgo cardiovascular y en el diagnóstico de placa aterosclerótica carotídea

Revista Espanola de Cardiologia

Volumn 64, Issue 4, 2011, Pages 305-311

  Masson, Walter ^a   Siniawski, Daniel ^a   Krauss, Juan ^a   Cagide, Arturo ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Atherosclerotic plaque; Cardiovascular risk scores; Carotid arteries; Primary prevention

Indexed keywords

LIPID;

ADULT; ANALYTIC METHOD; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; FEMALE; FRAMINGHAM 30 YEAR RISK SCORE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY PREVENTION; RECEIVER OPERATING CHARACTERISTIC ANALYSIS; SCORING SYSTEM;

ADULT; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RISK ASSESSMENT; ROC CURVE; SEX FACTORS; SMOKING; YOUNG ADULT;

EID: 79953273768     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2010.11.006     Document Type: Article

References (32)

1. Kastelein JJ. The future of best practice. Atherosclerosis. 1999;143:S17-21.
2. Wilson PWF, D'Agostino RB, Levy D, Belanger A, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-47. (Pubitemid 28213628)
3. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PFW, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham Study. Am Heart J. 2000;139:272-81. (Pubitemid 30090804)
4. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) Study. Circulation. 2002;105:310-5. (Pubitemid 34106178)
5. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987-1003. (Pubitemid 36712275)
6. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007;335:136-41. (Pubitemid 47172233)
7. Ridker PM, Buring JE, Rifai N, Cook RN. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA. 2007;297:611-9.
8. Baena-Diez JM, Ramos R, Marrugat J. Capacidad predictiva de las funciones de riesgo cardiovascular: limitaciones y oportunidades. Rev Esp Cardiol Supl. 2009;9:B4-13.
9. Grau M, Marrugat J. Funciones de riesgo en la prevención primaria de las enfermedades cardiovasculares. Rev Esp Cardiol. 2008;61:404-16. (Pubitemid 351838469)
10. Dawber TR, Meadors GF, Moore FEJ. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health. 1951;41:279-86.
11. Adult Treatment Panel III, Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA. 2001;285:2486-97.
12. Dhangana R, Murphy TP, Zafar AM, Qadeer FF, Cerezo JV, Ristuccia MB. Optimal use of Framingham risk scores to identify individuals for intensive medical risk factor modification. Circulation. 2009;120 Suppl:S423.
13. Pencina MJ, D'Agostino RB, Larson MG, Massaro JM, Vasan RS. Predicting the 30-Year Risk of Cardiovascular Disease. The Framingham Heart Study. Circulation. 2009;119:3078-84.
14. Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpoints obtained using two criteria based on the Receiver Operating Characteristic curve. Am J Epidemiol. 2006;163:670-5.
15. Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PWF, Houston-Miller N. Task Force #1 - Identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol. 2003;41:1863-74.
16. Berry JD, Lloyd-Jones DM, Garside DB, Greenland P. Framingham risk score and prediction of coronary heart disease death in young men. Am Heart J. 2007;154:80-6. (Pubitemid 46920482)
17. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality. A meta-analysis. JAMA. 2008;300:197-208.
18. Michos ED, Vasamreddy CR, Becker DM, Yanek LR, Moy TF, Fishman EK, et al. Women with a low Framingham Risk Score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. Am Heart J. 2005;150:1276-81. (Pubitemid 41773534)
19. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: The St. Francis Heart Study. J Am Coll Cardiol. 2005;46:158-65. (Pubitemid 40905145)
20. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459-67. (Pubitemid 46184197)
21. Touboul PJ, Vicaut E, Labreuche J, Belliard JP, Cohen S, Kownator S, et al. Correlation between the Framingham risk score and intima media thickness: The Paroi Artérielle et Risque Cardio-vasculaire (PARC) study. Atherosclerosis. 2007;192:363-9. (Pubitemid 46735936)
22. Touboul PR, Hernández RH, Kücükoglu S, Woo KS, Vicaut E, Labreuche J, et al. Carotid artery intima media thickness, plaque and Framingham cardiovascular score in Asia, Africa/Middle East and Latin America: the PARC-AALA Study. Int J Cardiovasc Imaging. 2007;23:557-67.
23. Christen AI, Elikir GD, Brandani LM, Miranda A, Graf S, Ramírez A, et al. Aterosclerosis subclínica y estimación de riesgo coronario: comparación de tablas de riesgo. Rev Argent Cardiol. 2006;74:433-40.
24. Grewal J, Anand S, Islam S, Lonn E, SHARE and SHARE-AP Investigators. Prevalence and predictors of subclinical atherosclerosis among asymptomatic "low risk" individuals in a multiethnic population. Atherosclerosis. 2008;197:435-42.
25. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, et al. Carotid intimamedia thickness and presence or absence of plaque improves prediction of coronary heart disease risk: The ARIC (Atherosclerosis Risk In Communities) Study. J Am Coll Cardiol. 2010;5:1600-7.
26. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14 Suppl 2:S1-113.
27. U.S. Preventive Services Task Force. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2009;151:474-82.
28. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr. 2008;21:93-111. (Pubitemid 351193107)
29. Genest J, McPherson R, Frohlich J, Anderson T, Campbell L, Carpentier A, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol. 2009;25:567-79.
30. Cuspidi C, Meani S, Valerio C, Fusi V, Sala C, Zanchetti A, et al. Carotid atherosclerosis and cardiovascular risk stratification: role and cost-effectiveness of echo-Doppler examination in untreated essential hypertensives. Blood Press. 2006;15:333-9.
31. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW. et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113:791-8.
32. Wyman RA, Mays ME, McBride PE, Stein JH. Ultrasound-detected carotid plaque as a predictor of cardiovascular events. Vasc Med. 2006;11:123-30. (Pubitemid 44122770)